This is the pilot version of Therapoid. Register or Sign in as a pilot user to collaborate.

Forums

COVID19 Clinical Trial Update | 27 March 2020

COVID19 Clinical Trial Update | 27 March 2020  

  By: Jason E. Barkeloo on March 28, 2020, 5:39 p.m.

Updated 3/27/20. No drug is currently FDA-approved to treat COVID-19. The FDA recently approved an NIH "adaptive" randomized clinical trial of investigational therapeutics for hospitalized COVID-19 pts; the investigational drug remdesivir is the 1st therapeutic w/in this trial. Existing drugs that are FDA-approved for other uses are also being studied in COVID-19 pts.

chloroquine, hydroxychloroquine +/- azithromycin,

remdesivir,

lopinavir/ritonavir,

losartan,

tocilizumab,

sarilumab,

nitric oxide,

favipiravir, umifenovir,

https://www.epocrates.com/e/guideline/03_19

Jason E. Barkeloo
Chairman & Founder, Open Therapeutics


 Last edited by:  Jason E. Barkeloo on March 28, 2020, 5:46 p.m., edited 2 times in total.

Re: COVID19 Clinical Trial Update | 27 March 2020  

  By: Anonymous on March 28, 2020, 8 p.m.

It has to be emphasized again: no drug is approved for Covid 19

Re: COVID19 Clinical Trial Update | 27 March 2020  

  By: Jason E. Barkeloo on April 11, 2020, 7:09 p.m.

How many drugs are now in testing?